"I think we identified something that can target early-stage disease... That’s a big deal..."
Authored by Cara Michelle Miller: Researchers have identified a protein that may prevent age-related macular degeneration (AMD), according to a new study published in the Developmental Cell on Oct. 2.
AMD is the leading cause of vision loss among older adults, affecting nearly 20 million Americans. As the population ages, this number is expected to rise significantly. Currently, there are no treatments that can stop AMD’s progression.
“I think we identified something that can target early-stage disease. ... That’s a big deal,” the study’s lead author Ruchira Singh, an associate professor of ophthalmology at the University of Rochester in New York, told The Epoch Times.
The study used human stem cells rather than animal models, which may give a more accurate depiction of what is happening in AMD, according to the researchers.
“Older research methods have been limited in their ability to capture important aspects of either healthy or diseased human cells,” Singh noted.
Researchers Identify the Protein Driving AMD
The researchers extracted human stem cells from healthy people and AMD patients and programmed them into cells lining the retina.
Compared to healthy people, AMD patients’ retinal cells overproduced a type of protein called tissue inhibitor of metalloproteinase 3 (TIMP3), which leads to a buildup of fats and proteins called drusen. Drusen are a marker of early-stage AMD.